Anyone here able to provide a summary of technegas versus the competitors that are used? I note that CTPS Is currently the dominant type and number one test for pulmonary embolism. So why so clinics / hospitals switch to tecnhegas?
Any insight appreciated
Ann: Cyclopharm Business Update on Significant Milestones-CYC.AX, page-6
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
91.0¢ |
Change
-0.020(2.15%) |
Mkt cap ! $101.1M | |||
| Open | High | Low | Value | Volume |
| 93.0¢ | 93.0¢ | 89.5¢ | $57.93K | 63.71K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5554 | 91.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 91.5¢ | 429 | 1 |
View Market Depth
| Last trade - 16.10pm 30/06/2025 (20 minute delay) ? |
| CYC (ASX) Chart |